CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Celltrion, Inc. et al. vs. Regeneron Pharmaceuticals, Inc.

Explore the PTAB proceeding IPR2023-00462 filed by Celltrion, Inc. et al. on 2023-01-17. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2023-00462

Filing Date

2023-01-17

Accorded Filing Date

2023-01-17

Institution Decision Date

2023-07-20

Last Modified Date

2024-05-24

Proceeding Type

IPR

Termination Date

2024-02-21

Trial Status

Terminated-Adverse Judgment

Parties & Counsel

Patent Owner / Respondent

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Patent Information

1 Patent Involved
Respondent Application Number 16159269
Respondent Patent Number 10464992
Respondent Inventor Eric FURFINE et al
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Address and Attorney/Agent Information

23 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name A&P - Regeneron (Prosecution)
Customer Number 191459
Address 601 Massachusetts Ave., NW, Washington, DC, 20001-3743, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
41408 David Marsh 202-942-5068
48001 Thomas Triolo 914-847-1612
48921 Stephen Gaudet 914-847-7376
50370 Neil Miyamoto 914-847-7175
50437 Frank Cottingham 914-593-1116
58583 Brian Cocca 914-847-1421
58714 Ilona Gont 914-847-1304
59668 Brandon Schurter 914-847-7000

Proceeding Documents

189
38

Granting Petitioner’s Motion to Expunge 37 C.F.R. § 42.56 ORDER

2024-03-01 FILING PARTY: BOARD
3004

Exhibit 3004 Exhibit

2024-03-01 FILING PARTY: BOARD
36

Petitioner's Unopposed Motion to Expunge MOTION

2024-02-21 FILING PARTY: PETITIONER
3003

Exhibit 3003 Exhibit

2024-02-21 FILING PARTY: BOARD
37

Adverse Judgment After Institution of Trial 37 C.F.R. § 42.73(b) ADVRSJUDG

2024-02-21 FILING PARTY: BOARD